Analysis of 3-year national reimbursement application data o…
Analysis of 3-year national reimbursement application data on etanercept and efalizumab for psoriasis.
Article, Chapter
Authors:
R.J.B. Driessen
Publication:
Volume:159,
Issue:3,
Page(s):760-761
Published:
2008
We were unable to find direct full text links for this item.